This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Search for Related Content PubMed PubMed Citation Related Collections Diabetes and Insulin

Eight-Point Glucose Testing Versus the Continuous Glucose Monitoring System in Evaluation of Glycemic Control in Type 1 Diabetes

DirecNet Coordinating Center, Jaeb Center for Health Research, Tampa, Florida 33647

Address all correspondence and requests for reprints to: Rosanna Fiallo-Scharer, M.D., c/o DirecNet Coordinating Center, Jaeb Center for Health Research, 15310 Amberly Drive, Suite 350, Tampa, Florida 33647. E-mail: direcnet{at}jaeb.org.

Context: Advantages/disadvantages of continuous vs. discrete glucose monitoring are not well documented.

Objective: Compare glucose profiles from home meters vs. continuous sensors.

Design: Randomized clinical trial conducted by the Diabetes Research in Children Network (DirecNet) to assess the utility of the GlucoWatch G2 Biographer.

Setting: Home glucose measurements.

Patients: Two hundred children (age, 7 to < 18 yr) with type 1 diabetes.

Intervention: At baseline, subjects were asked to wear the continuous glucose monitoring system (CGMS) sensor and perform meter tests at eight prespecified times of the day (eight-point testing) each for 3 d (2 d using both, 1 d eight-point testing only, 1 d CGMS only). Hemoglobin A1c was measured in a central laboratory.

Main Outcome Measure: Six-month hemoglobin A1c. This analysis looked at baseline glucose profiles/hemoglobin A1c.

Results: Only 10% of subjects completed full eight-point testing for 3 d, but median CGMS use was 70 h. Mean glucose was lower when measured by the CGMS compared with eight-point testing (183 ± 37 vs. 188 ± 41 mg/dl; 10.2 ± 2.1 vs.10.4 ± 2.3 mmol/liter; P = 0.009), especially overnight (2400–0400 h; 174 vs. 199 mg/dl; 9.7 vs. 11.1 mmol/liter; P < 0.001). Associations of hemoglobin A1c with mean glucose were similar for eight-point testing [slope 23 mg/dl per 1% (1.3 mmol/liter); correlation 0.40; P < 0.001] and CGMS [slope 19 mg/dl per 1% (1.1 mmol/liter); correlation 0.39; P < 0.001]. Postprandial excursions were lower for eight-point testing vs. CGMS, especially after dinner (mean excursion –17 vs. 63 mg/dl; –1.0 vs. 3.5 mmol/liter; P < 0.001).

Conclusions: Both methods gave similar mean glucose profiles and associations with hemoglobin A1c. Advantages of the CGMS were higher density of data and better detection of postprandial peaks. However, the CGMS may overestimate the frequency of low glucose levels, especially overnight.

This article has been cited by other articles:

				N. H. White, H. P. Chase, S. Arslanian, W. V. Tamborlane, and for the 4030 Study Group Comparison of Glycemic Variability Associated With Insulin Glargine and Intermediate-Acting Insulin When Used as the Basal Component of Multiple Daily Injections for Adolescents With Type 1 Diabetes Diabetes Care, March 1, 2009; 32(3): 387 - 393. [Abstract] [Full Text] [PDF]

				L. Messer, K. Ruedy, D. Xing, J. Coffey, K. Englert, K. Caswell, and B. Ives Educating Families on Real Time Continuous Glucose Monitoring: The DirecNet Navigator Pilot Study Experience The Diabetes Educator, January 1, 2009; 35(1): 124 - 135. [Abstract] [Full Text] [PDF]

				M. R. Burge, S. Mitchell, A. Sawyer, and D. S. Schade Continuous Glucose Monitoring: The Future of Diabetes Management Diabetes Spectr, April 1, 2008; 21(2): 112 - 119. [Abstract] [Full Text] [PDF]

				Diabetes Research in Children Network (DirecNet) S Relationship of A1C to Glucose Concentrations in Children With Type 1 Diabetes: Assessments by high-frequency glucose determinations by sensors Diabetes Care, March 1, 2008; 31(3): 381 - 385. [Abstract] [Full Text] [PDF]

				Z. T. Bloomgarden Type 1 Diabetes and Glucose Monitoring Diabetes Care, November 1, 2007; 30(11): 2965 - 2971. [Full Text] [PDF]

				The Diabetes Research in Children Network (DirecNe The Effect of Glucose Variability on the Risk of Microvascular Complications in Type 1 Diabetes: Response to Kilpatrick et al. and Bolli Diabetes Care, January 1, 2007; 30(1): 185 - 185. [Full Text] [PDF]